What is Oracle Corp's earnings per share (EPS)?

Oracle Corp (ORCL) reported diluted earnings per share of $5.83 for fiscal year 2026. This represents a 34.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Oracle Corp (ORCL) Financials

ORCL

Trailing 12 months to August 31, 2026

Revenue $71.8B +21.6% YoY

Net Income $18.8B +51.2% YoY

EPS (Diluted) $6.38 +47.7% YoY

Free Cash Flow -$28.7B -388.4% YoY

Market Cap $438.9B as of Oct 6, 2026

Price / Sales 6.1x on $71.8B revenue, trailing 12 months to August 31, 2026

Price / Earnings 23.3x on $18.8B net income, trailing 12 months to August 31, 2026

Price / Book 6.6x on $66.8B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Aug 31, 2026 Reported Sep 11, 2026 Currency USD FYE May

Newest figures come from the 10-Q for Q1 FY2027, filed Sep 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ORCL SEC filings page.

Oracle Corp (ORCL) reported $71.8B in revenue over the twelve months to Aug 31, 2026, up 21.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ORCL FY2026 2026-10-04

Oracle’s profits are expanding, but a sharp infrastructure spending step-up means cash left after reinvestment is currently negative.

Operating profitability remains intact: operating margin stayed near 31% while net margin reached 25.2% in FY2026, so the cash reversal is not explained by weaker reported earnings. Free cash flow moved from positive to negative across the last two reported years as capital expenditures reached $55.7B, identifying reinvestment as the mechanism.

Operating margin was 30.8% in FY2025 and 30.6% in FY2026, so the latest growth did not materially improve operating efficiency. Net margin reached 25.2%, showing that the operating result still translated into substantial bottom-line earnings.

Equity expanded sharply through FY2026, reducing reported debt-to-equity to 5.2x; the balance sheet is less equity-thin than in earlier years. That improvement reflects a larger equity base, not falling liabilities, which reached $219.3B, while the current ratio recovered to 1.1x.

Financial Health Signals

Financial Health Score 48/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Oracle Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Oracle Corp has an operating margin of 30.6%, meaning the company retains $31 of operating profit per $100 of revenue. This strong profitability earns a score of 95/100, reflecting efficient cost management and pricing power. This is down from 30.8% the prior year.

Growth

Oracle Corp's revenue surged 17.3% year-over-year to $67.4B, reflecting rapid business expansion. This strong growth earns a score of 71/100.

Leverage

Oracle Corp has elevated debt relative to equity (D/E of 5.16), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 11/100, reflecting increased financial risk.

Liquidity

Oracle Corp's current ratio of 1.11 is below the typical benchmark, resulting in a score of 25/100. However, the company holds substantial cash reserves (75% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow

While Oracle Corp generated $32.0B in operating cash flow, capex of $55.7B consumed most of it, leaving -$23.7B in free cash flow. This results in a low score of 10/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Oracle Corp earns a strong 40.0% return on equity (ROE), meaning it generates $40 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 77/100. This is down from 60.8% the prior year.

Altman Z-Score Distress

1.72

Oracle Corp scores 1.72, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($438.9B) relative to total liabilities ($219.3B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/7

Oracle Corp passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.88x

For every $1 of reported earnings, Oracle Corp generates $1.88 in operating cash flow ($32.0B OCF vs $17.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.48x

Oracle Corp earns $4.48 in operating income for every $1 of interest expense ($20.6B vs $4.6B). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$19.3B

YoY+29.6%

QoQ+0.8%

5Y CAGR+14.7%

10Y CAGR+8.5%

Oracle Corp generated $19.3B in revenue in Q1 2027. This represents an increase of 29.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

EBITDA

$10.2B

YoY+67.6%

QoQ+12.5%

Oracle Corp's EBITDA was $10.2B in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.6% from the same quarter a year earlier. Against the prior quarter it is up 12.5%.

Net Income

$4.8B

YoY+62.6%

QoQ+13.3%

Oracle Corp reported $4.8B in net income in Q1 2027. This represents an increase of 62.6% from the same quarter a year earlier. Against the prior quarter it is up 13.3%.

EPS (Diluted)

$1.56

YoY+54.5%

QoQ+7.6%

5Y CAGR+12.6%

10Y CAGR+13.8%

Oracle Corp earned $1.56 per diluted share (EPS) in Q1 2027. This represents an increase of 54.5% from the same quarter a year earlier. Against the prior quarter it is up 7.6%.

Cash & Balance Sheet

Free Cash Flow

-$5.4B

YoY-1390.6%

QoQ-188.1%

Oracle Corp recorded an outflow of $5.4B in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 1390.6% from the same quarter a year earlier. Against the prior quarter it is down 188.1%.

Cash & Debt

$36.4B

YoY+248.2%

QoQ+16.2%

5Y CAGR+9.5%

10Y CAGR+2.4%

Oracle Corp held $36.4B in cash as of Q1 2027; long-term debt is not reported for that period.

Dividends Per Share

$0.50

YoY0.0%

QoQ0.0%

5Y CAGR+9.3%

10Y CAGR+12.8%

Oracle Corp paid $0.50 per share in dividends in Q1 2027. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

3.02B

YoY+6.4%

QoQ+5.0%

5Y CAGR+2.0%

10Y CAGR-3.0%

Oracle Corp had 3.02B shares outstanding in Q1 2027. This represents an increase of 6.4% from the same quarter a year earlier. Against the prior quarter it is up 5.0%.

Margins & Returns

Operating Margin

34.8%

YoY+6.1pp

QoQ+2.8pp

Oracle Corp's operating margin was 34.8% in Q1 2027, reflecting core business profitability. This is up 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.

Net Margin

24.6%

YoY+5.0pp

QoQ+2.7pp

Oracle Corp's net profit margin was 24.6% in Q1 2027, showing the share of revenue converted to profit. This is up 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.

Return on Equity

7.1%

YoY-5.0pp

QoQ-2.7pp

Oracle Corp's ROE was 7.1% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.7 percentage points.

Gross Margin

Not reported for Q1 2027.

Capital Allocation

R&D Spending

$2.4B

YoY-3.6%

QoQ-8.1%

Oracle Corp invested $2.4B in research and development in Q1 2027. This represents a decrease of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 8.1%.

Capital Expenditures

$28.5B

YoY+235.2%

QoQ+72.8%

5Y CAGR+93.1%

10Y CAGR+57.7%

Oracle Corp invested $28.5B in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 235.2% from the same quarter a year earlier. Against the prior quarter it is up 72.8%.

Share Buybacks

Not reported for Q1 2027.

ORCL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ORCL quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$71.8B	$67.4B+17.3%	$57.4B+8.4%	$53.0B+6.0%	$50.0B+17.7%	$42.4B+4.8%	$40.5B+3.6%	$39.1B-1.1%	$39.5B+0.3%	$39.4B+4.2%	$37.8B+2.0%	$37.0B-3.1%	$38.2B-0.1%	$38.3B+2.9%	$37.2B+0.2%	$37.1B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$24.3B+5.5%	$23.0B+2.7%	$22.4B-5.5%	$23.7B	N/A	N/A	N/A
R&D Expenses	$10.2B	$10.3B+4.2%	$9.9B+10.6%	$8.9B+3.4%	$8.6B+19.4%	$7.2B+10.6%	$6.5B+7.6%	$6.1B+0.7%	$6.0B-1.0%	$6.1B-1.1%	$6.2B+6.3%	$5.8B+4.8%	$5.5B+7.2%	$5.2B+6.2%	$4.8B+7.2%	$4.5B
SG&A Expenses	$1.6B	$1.6B+1.0%	$1.6B+3.5%	$1.5B-2.0%	$1.6B+19.9%	$1.3B+5.0%	$1.3B+6.2%	$1.2B-6.6%	$1.3B-1.3%	$1.3B+9.4%	$1.2B+1.5%	$1.2B+7.2%	$1.1B+3.8%	$1.0B-3.2%	$1.1B-4.8%	$1.1B
Operating Income	$23.1B	$20.6B+16.6%	$17.7B+15.1%	$15.4B+17.3%	$13.1B+19.8%	$10.9B-28.2%	$15.2B+9.5%	$13.9B+2.7%	$13.5B+2.0%	$13.3B+2.7%	$12.9B+2.5%	$12.6B-9.1%	$13.9B-6.0%	$14.8B+0.5%	$14.7B+7.1%	$13.7B
EBITDA	N/A	$30.3B+26.6%	$23.9B+11.2%	$21.5B+11.9%	$19.2B+36.7%	$14.0B-22.5%	$18.1B+7.5%	$16.9B+2.5%	$16.5B+2.5%	$16.0B+4.5%	$15.4B+1.7%	$15.1B-9.7%	$16.7B-5.3%	$17.7B+0.3%	$17.6B+6.0%	$16.6B
Interest Expense	$5.1B	$4.6B+28.5%	$3.6B+1.8%	$3.5B+0.3%	$3.5B+27.2%	$2.8B+10.4%	$2.5B+25.1%	$2.0B-4.2%	$2.1B+2.8%	$2.0B+12.6%	$1.8B+22.6%	$1.5B+28.3%	$1.1B+25.1%	$914.0M+14.7%	$797.0M+4.0%	$766.0M
Income Tax	$2.8B	$2.5B+43.7%	$1.7B+34.8%	$1.3B+104.5%	$623.0M-33.2%	$932.0M+224.8%	-$747.0M-138.7%	$1.9B+62.7%	$1.2B-86.6%	$8.8B+296.6%	$2.2B-12.3%	$2.5B-12.3%	$2.9B+5.3%	$2.7B-7.5%	$3.0B-0.3%	$3.0B
Net Income	$18.8B	$17.0B+36.5%	$12.4B+18.9%	$10.5B+23.1%	$8.5B+26.6%	$6.7B-51.1%	$13.7B+35.6%	$10.1B-8.6%	$11.1B+209.0%	$3.6B-62.1%	$9.5B+6.2%	$8.9B-10.4%	$9.9B-9.3%	$11.0B+0.3%	$10.9B+9.5%	$10.0B
EPS (Basic)	N/A	$5.94+33.2%	$4.46+16.8%	$3.82+21.3%	$3.15+26.5%	$2.49-46.7%	$4.67+47.8%	$3.16+3.6%	$3.05+250.6%	$0.87-62.2%	$2.30+9.0%	$2.11-6.6%	$2.26-6.6%	$2.42+5.7%	$2.29+15.1%	$1.99
EPS (Diluted)	$6.38	$5.83+34.3%	$4.34+17.0%	$3.71+20.8%	$3.07+27.4%	$2.41-47.0%	$4.55+47.7%	$3.08+3.7%	$2.97+249.4%	$0.85-62.1%	$2.24+8.2%	$2.07-6.3%	$2.21-7.1%	$2.38+5.3%	$2.26+15.3%	$1.96
Diluted Shares (Avg)	N/A	2.91B+1.7%	2.87B+1.5%	2.82B+2.1%	2.77B-0.7%	2.79B-7.8%	3.02B-8.3%	3.29B-11.7%	3.73B-11.9%	4.24B+0.5%	4.22B-2.0%	4.30B-4.4%	4.50B-2.2%	4.60B-5.0%	4.84B-4.9%	5.09B

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$19.3B+29.6%	$19.2B+20.6%	$17.2B+21.7%	$16.1B+14.2%	$14.9B+12.2%	$15.9B+11.3%	$14.1B+6.4%	$14.1B+8.6%
R&D Expenses	$2.4B-3.6%	$2.6B-1.5%	$2.6B+7.3%	$2.6B+3.6%	$2.5B+8.0%	$2.7B+19.3%	$2.4B+8.1%	$2.5B+11.0%
SG&A Expenses	$376.0M0.0%	$444.0M-4.9%	$389.0M-0.3%	$409.0M+5.7%	$376.0M+5.0%	$467.0M+15.9%	$390.0M+3.4%	$387.0M+3.2%
Operating Income	$6.7B+57.3%	$6.1B+20.1%	$5.5B+25.4%	$4.7B+12.1%	$4.3B+7.2%	$5.1B+9.1%	$4.4B+16.2%	$4.2B+16.5%
EBITDA	$10.2B+67.6%	$9.1B+32.9%	$8.1B+37.4%	$6.9B+20.9%	$6.1B+12.7%	$6.8B+9.7%	$5.9B+11.5%	$5.7B+10.5%
Interest Expense	$1.4B+54.7%	$1.4B+47.1%	$1.2B+32.3%	$1.1B+22.1%	$923.0M+9.6%	$978.0M+11.4%	$892.0M+1.8%	$866.0M-2.5%
Income Tax	$847.0M+69.4%	$1.1B+46.7%	$695.0M+35.7%	$207.0M-13.4%	$500.0M+108.3%	$726.0M+13.8%	$512.0M+10.3%	$239.0M+10.1%
Net Income	$4.8B+62.6%	$4.2B+22.6%	$3.7B+26.7%	$6.1B+94.7%	$2.9B-0.1%	$3.4B+9.0%	$2.9B+22.3%	$3.2B+25.9%
EPS (Basic)	$1.58+51.9%	$1.47+20.5%	$1.29+22.9%	$2.14+89.4%	$1.04-1.9%	$1.22+6.1%	$1.05+20.7%	$1.13+24.2%
EPS (Diluted)	$1.56+54.5%	$1.45+21.8%	$1.27+24.5%	$2.10+90.9%	$1.01-1.9%	$1.19+7.2%	$1.02+20.0%	$1.10+23.6%
Diluted Shares (Avg)	3.00B+3.1%	N/A	2.91B+1.3%	2.92B+1.8%	2.91B+2.0%	N/A	2.87B+2.0%	2.87B+1.8%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

ORCL Balance Sheet

ORCL quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$261.8B+55.5%	$168.4B+19.4%	$141.0B+4.9%	$134.4B+23.0%	$109.3B-16.6%	$131.1B+13.6%	$115.4B+6.2%	$108.7B-21.1%	$137.9B+2.1%	$135.0B+20.3%	$112.2B+1.2%	$110.9B+22.9%	$90.3B+10.3%	$81.8B+4.4%	$78.3B
Current Assets	$46.6B+89.5%	$24.6B+9.0%	$22.6B+7.4%	$21.0B-33.6%	$31.6B-43.1%	$55.6B+6.6%	$52.1B+12.4%	$46.4B-39.1%	$76.2B+2.2%	$74.5B+15.9%	$64.3B+2.9%	$62.5B+29.9%	$48.1B+15.4%	$41.7B+4.2%	$40.0B
Cash & Equivalents	$31.3B+190.1%	$10.8B+3.2%	$10.5B+7.1%	$9.8B-54.3%	$21.4B-29.0%	$30.1B-19.2%	$37.2B+81.5%	$20.5B-5.1%	$21.6B-0.8%	$21.8B+8.1%	$20.2B-7.2%	$21.7B+22.2%	$17.8B+21.6%	$14.6B-2.3%	$15.0B
Short-Term Investments	$605.0M+45.1%	$417.0M+101.4%	$207.0M-50.9%	$422.0M-18.7%	$519.0M-96.8%	$16.5B+182.8%	$5.8B-66.4%	$17.3B-62.1%	$45.6B+3.0%	$44.3B+23.1%	$36.0B+10.2%	$32.7B+55.1%	$21.1B+19.6%	$17.6B+12.0%	$15.7B
Inventory	N/A	$303.0M-9.3%	$334.0M+12.1%	$298.0M-5.1%	$314.0M+121.1%	$142.0M-32.7%	$211.0M-34.1%	$320.0M-19.6%	$398.0M+32.7%	$300.0M+41.5%	$212.0M-32.5%	$314.0M+66.1%	$189.0M-21.3%	$240.0M+51.9%	$158.0M
Accounts Receivable	$10.4B+21.3%	$8.6B+8.7%	$7.9B+13.9%	$6.9B+16.2%	$6.0B+10.1%	$5.4B-2.6%	$5.6B+8.1%	$5.1B0.0%	$5.1B-3.1%	$5.3B-1.6%	$5.4B-4.1%	$5.6B-7.7%	$6.1B+0.6%	$6.0B-5.1%	$6.4B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$62.3B+0.1%	$62.2B0.0%	$62.2B0.0%	$62.3B+42.1%	$43.8B-0.3%	$43.9B+0.4%	$43.8B0.0%	$43.8B+0.1%	$43.8B+1.6%	$43.0B+24.4%	$34.6B+1.5%	$34.1B+15.0%	$29.7B+8.4%	$27.3B+8.9%	$25.1B
Total Liabilities	$219.3B+48.2%	$147.9B+11.8%	$132.3B-0.8%	$133.3B+15.4%	$115.5B-8.2%	$125.9B+21.8%	$103.4B+18.9%	$86.9B-5.0%	$91.5B+12.8%	$81.1B+25.0%	$64.9B+4.3%	$62.2B+43.4%	$43.4B+16.7%	$37.2B+7.3%	$34.6B
Current Liabilities	$41.8B+27.9%	$32.6B+3.5%	$31.5B+36.6%	$23.1B+18.3%	$19.5B-19.3%	$24.2B+40.5%	$17.2B-7.7%	$18.6B-2.6%	$19.1B-20.9%	$24.2B+40.5%	$17.2B+13.2%	$15.2B+5.7%	$14.4B+11.8%	$12.9B-16.4%	$15.4B
Non-Current Liabilities	$176.9B+54.2%	$114.7B+14.5%	$100.2B-8.7%	$109.7B+14.8%	$95.6B-5.4%	$101.0B+18.1%	$85.5B+26.3%	$67.7B-5.8%	$71.9B+27.0%	$56.6B+19.9%	$47.2B+1.3%	$46.6B+63.9%	$28.4B+19.5%	$23.8B+26.2%	$18.9B
Long-Term Debt	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$42.5B+107.9%	$20.5B+135.0%	$8.7B+711.2%	$1.1B+117.3%	-$6.2B-218.7%	$5.2B-56.6%	$12.1B-44.6%	$21.8B-53.0%	$46.4B-13.9%	$53.9B+13.9%	$47.3B-2.8%	$48.7B+3.8%	$46.9B+5.0%	$44.6B+2.2%	$43.7B
Retained Earnings	-$4.3B+72.2%	-$15.5B+31.6%	-$22.6B+18.1%	-$27.6B+11.9%	-$31.3B-55.7%	-$20.1B-58.5%	-$12.7B-263.2%	-$3.5B-118.3%	$19.1B-30.8%	$27.6B+15.5%	$23.9B-9.9%	$26.5B+2.1%	$26.0B+0.4%	$25.9B-0.9%	$26.1B

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$303.3B+68.1%	$261.8B+55.5%	$245.2B+52.0%	$205.0B+38.1%	$180.4B+25.1%	$168.4B+19.4%	$161.4B+17.7%	$148.5B+10.5%
Current Assets	$55.6B+125.8%	$46.6B+89.5%	$54.9B+82.2%	$34.4B+46.2%	$24.6B+6.8%	$24.6B+9.0%	$30.1B+43.0%	$23.5B+21.8%
Cash & Equivalents	$36.4B+248.2%	$31.3B+190.1%	$38.5B+120.9%	$19.2B+75.9%	$10.4B-1.6%	$10.8B+3.2%	$17.4B+83.6%	$10.9B+32.7%
Short-Term Investments	$708.0M+26.4%	$605.0M+45.1%	$677.0M+62.4%	$525.0M+41.9%	$560.0M+89.8%	$417.0M+101.4%	$417.0M-1.4%	$370.0M-17.0%
Inventory	N/A	N/A	N/A	N/A	N/A	$303.0M-9.3%	N/A	N/A
Accounts Receivable	$11.4B+28.8%	$10.4B+21.3%	$10.7B+33.1%	$9.4B+15.4%	$8.8B+10.2%	$8.6B+8.7%	$8.1B+10.3%	$8.2B+20.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$62.3B+0.1%	$62.3B+0.1%	$62.3B+0.2%	$62.2B0.0%	$62.2B-0.1%	$62.2B0.0%	$62.2B-0.1%	$62.2B0.0%
Total Liabilities	$236.5B+51.3%	$219.3B+48.2%	$206.7B+42.9%	$175.0B+29.9%	$156.3B+17.2%	$147.9B+11.8%	$144.6B+10.0%	$134.7B+3.3%
Current Liabilities	$47.5B+19.2%	$41.8B+27.9%	$40.7B+37.5%	$37.8B+30.1%	$39.9B+24.4%	$32.6B+3.5%	$29.6B+19.0%	$29.1B+19.0%
Non-Current Liabilities	$188.5B+62.7%	$176.9B+54.2%	$165.5B+44.5%	$136.7B+30.0%	$115.9B+14.9%	$114.7B+14.5%	$114.5B+8.0%	$105.2B-0.3%
Total Equity	$66.8B+176.4%	$42.5B+107.9%	$38.5B+130.1%	$30.0B+117.9%	$24.2B+123.3%	$20.5B+135.0%	$16.7B+197.5%	$13.7B+255.6%
Retained Earnings	-$1.1B+92.1%	-$4.3B+72.2%	-$7.1B+59.2%	-$9.4B+50.9%	-$14.1B+32.9%	-$15.5B+31.6%	-$17.4B+29.2%	-$19.0B+25.1%

Not reported in any period shown, so not listed: Long-Term Debt.

ORCL Cash Flow Statement

ORCL quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$46.9B	$32.0B+53.6%	$20.8B+11.5%	$18.7B+8.8%	$17.2B+79.9%	$9.5B-40.0%	$15.9B+20.9%	$13.1B-9.7%	$14.6B-5.4%	$15.4B+8.9%	$14.1B+3.2%	$13.7B-6.1%	$14.6B-2.3%	$14.9B+4.9%	$14.2B+3.5%	$13.7B
Depreciation & Amortization	N/A	$9.6B+55.0%	$6.2B+1.4%	$6.1B+0.5%	$6.1B+95.6%	$3.1B+7.1%	$2.9B-1.8%	$3.0B+1.7%	$2.9B+4.8%	$2.8B+13.6%	$2.5B-2.3%	$2.5B-12.3%	$2.9B-1.6%	$2.9B-0.8%	$2.9B+0.5%	$2.9B
Stock-Based Compensation	N/A	$4.8B+2.9%	$4.7B+17.6%	$4.0B+12.0%	$3.5B+35.7%	$2.6B+42.2%	$1.8B+15.5%	$1.6B-3.8%	$1.7B+2.9%	$1.6B+19.0%	$1.4B+30.2%	$1.0B+11.1%	$933.0M+15.9%	$805.0M+6.6%	$755.0M+14.6%	$659.0M
Capital Expenditures	$75.7B	$55.7B+162.4%	$21.2B+209.0%	$6.9B-21.0%	$8.7B+92.8%	$4.5B+111.3%	$2.1B+36.5%	$1.6B-5.8%	$1.7B-4.4%	$1.7B-14.1%	$2.0B+70.0%	$1.2B-14.5%	$1.4B+139.8%	$580.0M-10.8%	$650.0M+0.3%	$648.0M
Free Cash Flow	-$28.7B	-$23.7B-5911.7%	-$394.0M-103.3%	$11.8B+39.4%	$8.5B+68.5%	$5.0B-63.4%	$13.8B+18.8%	$11.6B-10.2%	$12.9B-5.6%	$13.7B+12.8%	$12.1B-3.1%	$12.5B-5.3%	$13.2B-8.0%	$14.3B+5.7%	$13.6B+3.7%	$13.1B
Investing Cash Flow	-$71.7B	-$51.9B-138.8%	-$21.7B-195.0%	-$7.4B+79.8%	-$36.5B-425.2%	$11.2B+185.7%	-$13.1B-233.1%	$9.8B-62.9%	$26.6B+572.1%	-$5.6B+73.8%	-$21.5B-317.0%	-$5.2B	N/A	N/A	-$6.0B+28.9%	-$8.4B
Financing Cash Flow	$53.2B	$40.3B+3568.9%	$1.1B+110.4%	-$10.6B-233.4%	$7.9B+127.2%	-$29.1B-180.7%	-$10.4B-69.2%	-$6.1B+85.4%	-$42.1B-321.3%	-$10.0B-209.9%	$9.1B+191.0%	-$10.0B	N/A	N/A	-$8.5B-39.4%	-$6.1B
Dividends Paid	$5.9B	$5.8B+22.0%	$4.7B+8.0%	$4.4B+19.7%	$3.7B+6.1%	$3.5B+12.9%	$3.1B-0.2%	$3.1B+4.7%	$2.9B-6.6%	$3.1B+19.3%	$2.6B+3.5%	$2.5B+12.7%	$2.3B+3.5%	$2.2B+52.0%	$1.4B+18.9%	$1.2B
Share Buybacks	N/A	$95.0M-84.2%	$600.0M-50.1%	$1.2B-7.5%	$1.3B-92.0%	$16.2B-22.4%	$20.9B+8.8%	$19.2B-46.8%	$36.1B+218.5%	$11.3B+218.6%	$3.6B-65.9%	$10.4B+29.1%	$8.1B-17.6%	$9.8B-11.0%	$11.0B+88.2%	$5.9B

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	$23.1B+183.8%	$14.6B+137.5%	$7.2B+20.5%	$2.1B+58.4%	$8.1B+9.6%	$6.2B+1.2%	$5.9B+8.4%	$1.3B+811.9%
Depreciation & Amortization	$3.5B+91.6%	$3.0B+70.9%	$2.7B+70.9%	$2.2B+45.8%	$1.8B+28.2%	$1.7B+11.7%	$1.6B+0.1%	$1.5B-3.5%
Stock-Based Compensation	$1.1B+0.3%	N/A	$1.3B+10.9%	$1.2B-1.2%	$1.1B+11.6%	N/A	$1.2B+14.3%	$1.2B+13.7%
Capital Expenditures	$28.5B+235.2%	$16.5B+81.6%	$18.6B+217.9%	$12.0B+203.1%	$8.5B+269.2%	$9.1B+224.5%	$5.9B+250.2%	$4.0B+267.6%
Free Cash Flow	-$5.4B-1390.6%	-$1.9B+35.9%	-$11.5B-16274.6%	-$10.0B-273.9%	-$362.0M-107.1%	-$2.9B-189.0%	$71.0M-98.1%	-$2.7B-184.5%
Investing Cash Flow	-$28.6B-227.8%	-$15.9B-72.9%	-$19.5B-227.0%	-$7.7B-103.6%	-$8.7B-215.3%	-$9.2B-232.0%	-$6.0B-235.2%	-$3.8B-203.3%
Financing Cash Flow	$13.1B+6143.3%	-$5.9B-55.0%	$31.5B+380.2%	$14.5B+393.1%	$210.0M+104.6%	-$3.8B-67.7%	$6.6B+366.3%	$2.9B+228.4%
Dividends Paid	$1.6B+10.8%	$1.5B+7.1%	$1.4B+28.4%	$1.4B+28.4%	$1.4B+28.1%	$1.4B+27.3%	$1.1B+1.8%	$1.1B+1.7%
Share Buybacks	N/A	$0-100.0%	$0-100.0%	$0-100.0%	$95.0M-36.7%	$150.0M-1.3%	$150.0M-66.7%	$150.0M-66.7%

ORCL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ORCL quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	61.7%+0.8pp	60.9%+0.4pp	60.5%-1.5pp	62.0%	N/A	N/A	N/A
Operating Margin	30.6%-0.2pp	30.8%+1.8pp	29.0%+2.8pp	26.2%+0.5pp	25.7%-11.8pp	37.6%+2.0pp	35.6%+1.3pp	34.3%+0.6pp	33.7%-0.5pp	34.2%+0.2pp	34.0%-2.3pp	36.3%-2.3pp	38.6%-0.9pp	39.5%+2.6pp	36.9%
Net Margin	25.2%+3.5pp	21.7%+1.9pp	19.8%+2.7pp	17.0%+1.2pp	15.8%-18.1pp	34.0%+8.0pp	25.9%-2.1pp	28.1%+18.9pp	9.1%-15.9pp	25.0%+1.0pp	24.0%-2.0pp	26.0%-2.6pp	28.6%-0.8pp	29.4%+2.5pp	26.9%
Return on Equity	40.0%-20.9pp	60.8%-59.4pp	120.3%-672.2pp	792.5%	N/A	262.4%+178.5pp	83.9%+33.1pp	50.9%+43.1pp	7.7%-9.8pp	17.5%-1.3pp	18.8%-1.6pp	20.4%-2.9pp	23.4%-1.1pp	24.5%+1.6pp	22.9%
Return on Assets	6.5%-0.9pp	7.4%0.0pp	7.4%+1.1pp	6.3%+0.2pp	6.2%-4.3pp	10.5%+1.7pp	8.8%-1.4pp	10.2%+7.6pp	2.6%-4.4pp	7.0%-0.9pp	7.9%-1.0pp	9.0%-3.2pp	12.1%-1.2pp	13.4%+0.6pp	12.7%
Current Ratio	1.11+0.4x	0.750.0x	0.71-0.2x	0.91-0.7x	1.62-0.7x	2.30-0.7x	3.03+0.5x	2.49-1.5x	3.98+0.9x	3.08-0.7x	3.74-0.4x	4.11+0.8x	3.34+0.1x	3.24+0.6x	2.60
Debt-to-Equity	5.16-2.1x	7.23-8.0x	15.20-109.0x	124.24	N/A	24.03+15.5x	8.56+4.6x	3.99+2.0x	1.97+0.5x	1.51+0.1x	1.37+0.1x	1.28+0.4x	0.93+0.1x	0.830.0x	0.79
Asset Turnover	0.26-0.1x	0.340.0x	0.380.0x	0.370.0x	0.39+0.1x	0.310.0x	0.340.0x	0.36+0.1x	0.290.0x	0.28-0.1x	0.330.0x	0.34-0.1x	0.420.0x	0.450.0x	0.47
FCF Margin	-35.2%-34.5pp	-0.7%-23.0pp	22.3%+5.3pp	17.0%+5.1pp	11.8%-22.1pp	34.0%+4.3pp	29.6%-3.0pp	32.6%-2.0pp	34.7%+2.6pp	32.0%-1.7pp	33.7%-0.8pp	34.5%-3.0pp	37.5%+1.0pp	36.5%+1.2pp	35.3%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Margin	34.8%+6.1pp	32.0%-0.2pp	31.8%+1.0pp	29.5%-0.6pp	28.6%-1.3pp	32.1%-0.7pp	30.8%+2.6pp	30.0%+2.0pp
Net Margin	24.6%+5.0pp	21.9%+0.4pp	21.6%+0.9pp	38.2%+15.8pp	19.6%-2.4pp	21.6%-0.5pp	20.8%+2.7pp	22.4%+3.1pp
Return on Equity	7.1%-5.0pp	9.9%-6.9pp	9.7%-7.9pp	20.5%-2.4pp	12.1%-15.0pp	16.8%-19.3pp	17.5%-25.1pp	22.9%-41.8pp
Return on Assets	1.6%-0.1pp	1.6%-0.4pp	1.5%-0.3pp	3.0%+0.9pp	1.6%-0.4pp	2.0%-0.2pp	1.8%+0.1pp	2.1%+0.3pp
Current Ratio	1.17+0.6x	1.11+0.4x	1.35+0.3x	0.91+0.1x	0.62-0.1x	0.750.0x	1.02+0.2x	0.810.0x
Debt-to-Equity	3.54-2.9x	5.16-2.1x	5.37-3.3x	5.84-4.0x	6.47-5.9x	7.23-8.0x	8.65-14.7x	9.80-23.9x
Asset Turnover	0.060.0x	0.070.0x	0.070.0x	0.080.0x	0.080.0x	0.090.0x	0.090.0x	0.090.0x
FCF Margin	-27.9%-25.5pp	-9.8%+8.6pp	-66.8%-67.3pp	-62.1%-43.1pp	-2.4%-40.9pp	-18.4%-41.4pp	0.5%-28.1pp	-19.0%-11.7pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Oracle Corp ORCL	FY2026	$67.4B	$17.0B	25.2%	$438.9B	48/100
Palantir Technologies Inc. PLTR	FY2025	$4.5B	$1.6B	36.3%	$455.1B	79/100
Microsoft Corp MSFT	FY2026	$331.8B	$133.7B	40.3%	$3.9T	79/100
Palo Alto Networks, Inc. PANW	FY2026	$11.5B	$307.0M	2.7%	$332.7B	57/100
NetApp, Inc NTAP	FY2026	$6.2B	$1.3B	20.5%	$44.0B	72/100
F5 FFIV	FY2025	$3.1B	$692.4M	22.4%	$26.0B	68/100

Where Oracle Corp Ranks

Frequently Asked Questions

What is Oracle Corp's annual revenue?

Oracle Corp (ORCL) reported $67.4B in total revenue for fiscal year 2026. This represents a 17.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Oracle Corp's revenue growing?

Oracle Corp (ORCL) revenue grew by 17.3% year-over-year, from $57.4B to $67.4B in fiscal year 2026.

Is Oracle Corp profitable?

Yes, Oracle Corp (ORCL) reported a net income of $17.0B in fiscal year 2026, with a net profit margin of 25.2%.

What is Oracle Corp's EBITDA?

Oracle Corp (ORCL) had EBITDA of $30.3B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Oracle Corp's operating margin?

Oracle Corp (ORCL) had an operating margin of 30.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Oracle Corp's net profit margin?

Oracle Corp (ORCL) had a net profit margin of 25.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Oracle Corp pay dividends?

Yes, Oracle Corp (ORCL) paid $2.00 per share in dividends during fiscal year 2026.

What is Oracle Corp's return on equity (ROE)?

Oracle Corp (ORCL) has a return on equity of 40.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Oracle Corp's free cash flow?

Oracle Corp (ORCL) recorded an outflow of $23.7B in free cash flow during fiscal year 2026. This represents a -5911.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Oracle Corp's operating cash flow?

Oracle Corp (ORCL) generated $32.0B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Oracle Corp's total assets?

Oracle Corp (ORCL) had $261.8B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Oracle Corp's capital expenditures?

Oracle Corp (ORCL) invested $55.7B in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Oracle Corp spend on research and development?

Oracle Corp (ORCL) invested $10.3B in research and development during fiscal year 2026.

Does Oracle Corp buy back shares?

Yes, Oracle Corp (ORCL) spent $95.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Oracle Corp have outstanding?

Oracle Corp (ORCL) had 2.88B shares outstanding as of fiscal year 2026.

What is Oracle Corp's current ratio?

Oracle Corp (ORCL) had a current ratio of 1.11 as of fiscal year 2026, which is considered adequate.

What is Oracle Corp's debt-to-equity ratio?

Oracle Corp (ORCL) had a debt-to-equity ratio of 5.16 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Oracle Corp's return on assets (ROA)?

Oracle Corp (ORCL) had a return on assets of 6.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Oracle Corp's P/E ratio?

Oracle Corp (ORCL) trades at 23.3x earnings, its market capitalization divided by net income of $18.8B net income, trailing 12 months to August 31, 2026. The market capitalization is $438.9B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Oracle Corp's price-to-sales ratio?

Oracle Corp (ORCL) trades at 6.1x sales, its market capitalization divided by revenue of $71.8B revenue, trailing 12 months to August 31, 2026. The market capitalization is $438.9B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Oracle Corp's Altman Z-Score?

Oracle Corp (ORCL) has an Altman Z-Score of 1.72, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Oracle Corp's Piotroski F-Score?

Oracle Corp (ORCL) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Oracle Corp's earnings high quality?

Oracle Corp (ORCL) has an earnings quality ratio of 1.88x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Oracle Corp cover its interest payments?

Oracle Corp (ORCL) has an interest coverage ratio of 4.48x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Oracle Corp?

Oracle Corp (ORCL) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.